Estimates Revisions GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 12:05:07 16/06/2026 BST			5-day change	1st Jan Change
2,202.80 ^INR	+3.78%		+0.37%	-10.95%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	NOVO NORDISK A/S
	AMGEN INC.
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.